clevudine
Sign in to saveAlso known as L-FMAU, Levovir
Clevudine (INN) is an antiviral drug for the treatment of hepatitis B (HBV). It is already approved for HBV in South Korea and the Philippines. It is marketed by Bukwang Pharmaceuticals in South Korea under the tradenames Levovir and Revovir.
Research
250 papers- Clevudine Induced Mitochondrial Myopathy.Journal of Korean medical science · 2017
- Clevudine for hepatitis B.Drugs of today (Barcelona, Spain : 1998) · 2009
- Clevudine for the treatment of chronic hepatitis B virus infection.Expert opinion on investigational drugs · 2005
- Clevudine: a promising therapy for the treatment of chronic hepatitis B.Expert opinion on investigational drugs · 2008
- Clevudine University of Georgia/Abbott/Bukwang/Triangle/Yale University.Current opinion in investigational drugs (London, England : 2000) · 2000
via PubMed
Wikidata facts
- Mass
- 260.081
Show 5 more facts
- chemical formula
- C₁₀H₁₃FN₂O₅
- Commons category
- Clevudine
- isomeric SMILES
- CC1=CN(C(=O)NC1=O)[C@@H]2[C@@H]([C@H]([C@@H](O2)CO)O)F
- canonical SMILES
- CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F
- defined daily dose
- 30
via Wikidata · CC0
~1 min read
Article
1 sectionsContents
- References
Clevudine (INN) is an antiviral drug for the treatment of hepatitis B (HBV). It is already approved for HBV in South Korea and the Philippines. It is marketed by Bukwang Pharmaceuticals in South Korea under the tradenames Levovir and Revovir.
Researchers in South Korea are testing clevudine at lower doses in combination with adefovir for continued use.
Available in 9 languages
via Wikidata sitelinks · CC0